The increasing burden of depression

Area of Science:

• Psychiatry
• Epidemiology
• Public Health

Background:

• Lifetime prevalence of depression ranges from 10% to 15% globally.
• Mood disorders exhibit varying 12-month prevalence rates, e.g., 9% in the US versus 3% in Japan.
• Depression is linked to significant mortality and morbidity, impacting quality of life.

Purpose of the Study:

• To provide a brief overview of depression's impact on quality of life.
• To highlight the societal and familial burden of depression.
• To underscore the public health significance of depressive disorders.

Main Methods:

• Review of recent epidemiological surveys and population studies.
• Analysis of data on prevalence, mortality, and functional impairment.
• Synthesis of findings from the World Mental Health and Diagnostic and Statistical Manual of Mental Disorders.

Main Results:

• Depression elevates suicide risk over 20-fold and is a risk factor for cardiovascular death.
• Increased depressive symptom severity correlates with higher all-cause mortality, including stroke.
• Functional impairments include decreased productivity, absenteeism, and presenteeism, costing billions annually.

Conclusions:

• Depression is a major cause of disease burden, projected to be the leading cause by 2030.
• The impact of depression extends beyond the individual, affecting families and society.
• Addressing depression is crucial for public health and economic well-being.